Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vardenafil effects on proteomic patterns in erectile dysfunction and diabetes mellitus
2006-001002-83Phase 4Active
- Sponsor
- Hospital Clínico San Carlos
- Start
- May 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of vardenafil in erectile dysfunction (ED) and type 2 diabetes mellitus (T2DM), sponsored by Hospital Clínico San Carlos. Primary endpoint: Proteomic pattern changes in plasma and mononuclear cells. Started May 2006; status: active.
02
Drugs
vardenafil
03
Conditions
erectile dysfunction (ED)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2006-001002-83.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001002-83.